We went from 40% invested to 65% invested concentrated in biotech and pharma. Climbing the proverbial wall of worry showing bullish divergence.
We went from 40% invested to 65% invested concentrated in biotech and pharma. Climbing the proverbial wall of worry showing bullish divergence.